On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...

Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience.

Dexcom is transforming its Stelo CGM into a whole-family wellness device, securing FDA clearance for pediatric use and debuting new AI tools.

On June 8, at the American Diabetes Association meeting, Adaptyx Biosciences put up data the field has chased for ten years ...

Abbott’s recent regulatory authorization in Europe for a dual-analyte sensor has sparked a debate about the benefits and challenges of the new technology. Medtech firms are working on sensors that can ...

A continuous glucose monitor is a coin-sized plastic disc, a filament thinner than a hair that sits just under the skin, and ...

OTC glucose monitors are moving into wearable health tech, but the clearest benefits remain for diabetes and prediabetes ...

Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...

Samsung Galaxy Watch blood sugar tracking is still a rumor, not reality. Here’s the timeline, research, current options, and ...

AI can help read CGM data for glucose forecasts, but broader health profiling still faces validation, privacy, and governance ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A non-prescription continuous glucose monitor has been cleared for use in pediatric patients aged 2 years and older with diabetes who do not use insulin. HealthDay News — The U.S. Food and Drug ...